9 Meters Biopharma, Inc. filed its 10-K on Mar 28, 2023 for the period ending Dec 31, 2022. In this report its auditor, Mayer Hoffman McCann P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
2023 | Bidding Procedure Approved for 9 Meters Biopharma, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 14 | |
+76.43% | 5.87B | |
+2.76% | 988M | |
+46.03% | 955M | |
+2.49% | 669M | |
-.--% | 600M | |
-2.15% | 593M | |
+10.28% | 536M | |
-.--% | 500M | |
-2.10% | 470M |
- Stock Market
- Equities
- NMTRQ Stock
- News 9 Meters Biopharma, Inc.
- 9 Meters Biopharma, Inc. Auditor Raises 'Going Concern' Doubt